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Understanding the prebiotic 
potential of different dietary fibers 
using an in vitro continuous adult 
fermentation model (PolyFermS)
Sophie A. Poeker1, Annelies Geirnaert1, Laura Berchtold1, Anna Greppi1, Lukasz Krych2, 
Robert E. Steinert3, Tomas de Wouters1 & Christophe Lacroix1
Consumption of fermentable dietary fibers (DFs), which can induce growth and/or activity of specific 
beneficial populations, is suggested a promising strategy to modulate the gut microbiota and restore 
health in microbiota-linked diseases. Until today, inulin and fructo-oligosaccharides (FOS) are the 
best studied DFs, while little is known about the gut microbiota-modulating effects of β-glucan, 
α-galactooligosaccharide (α-GOS) and xylo-oligosaccharide (XOS). Here, we used three continuous in 
vitro fermentation PolyFermS model to study the modulating effect of these DFs on two distinct human 
adult proximal colon microbiota, independently from the host. Supplementation of DFs, equivalent 
to a 9 g daily intake, induced a consistent metabolic response depending on the donor microbiota. 
Irrespective to the DF supplemented, the Bacteroidaceae-Ruminococcaceae dominated microbiota 
produced more butyrate (up to 96%), while the Prevotellaceae-Ruminococcaceae dominated microbiota 
produced more propionate (up to 40%). Changes in abundance of specific bacterial taxa upon DF 
supplementation explained the observed changes in short-chain fatty acid profiles. Our data suggest 
that the metabolic profile of SCFA profile may be the most suitable and robust read-out to characterize 
microbiota-modulating effects of a DF and highlights importance to understand the inter-individual 
response to a prebiotic treatment for mechanistic understanding and human application.
The human gut microbiota is composed of around 1014 bacterial cells that belong to more than 1000 species1, 
dominated by members belonging to the two phyla, Firmicutes and Bacteroidetes1,2. Diet is known to strongly 
influence the composition of the gut microbiota as well as metabolites, dominated by the canonical short chain 
fatty acids (SCFAs) acetate, propionate and butyrate3,4. Among healthy individuals, compositional and functional 
properties of the microbiome vary substantially, leading to highly variable responses to dietary interventions5–9. 
Baseline bacterial composition of the host microbiome has repeatedly been observed to be a key factor to explain 
responses of the gut microbiota to different dietary interventions10–12. Within the collective genome of several 
millions genes, the microbiome harbors the capacity of primary degradation of substrates by specialized bacteria, 
cross-feeding and competition, making the stratification of microbiota response profiles a major challenge in the 
field1,10.
Around 40 g of complex carbohydrates reach the colon each day after escaping breakdown by host 
enzymes9,13,14. Endogenous enzymes are unable to degrade numerous complex carbohydrates and plant poly-
saccharides4. Non-digestible dietary fibers have been shown to have a beneficial effect on intestinal wellbeing 
acting as bulking agent and substrates for growth and activity of specific endogenous bacterial populations within 
the gastrointestinal tract (GIT)15. The breakdown of the complex carbohydrates by the gut microbiota is a key 
factor for the stability and diversity of the intestinal ecosystem yielding energy not only for the host, but also 
for its microbiota. The presence of end metabolites such as the SCFAs acetate, propionate and butyrate, and 
absence of intermediate metabolite accumulation, such as for lactate, formate and succinate, are generally rec-
ognized as markers for a healthy microbiome16. Metabolism of fibers is occurring in the colon, especially in the 
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proximal colon resulting in an increased production of organic acids and a decrease in luminal pH of 5.5–5.917. 
Acidification but more importantly the production of intermediate and end-metabolites have important conse-
quences for the microbial composition, the establishment of key bacterial interactions and the proper functioning 
of host physiology18,19. Microbial SCFAs impact on gut health, as energy source for the intestinal epithelium and 
epigenetic factor influencing immune response, epithelial integrity, electrolytes re-absorption and gut motility. 
Butyrate is an energy substrate used by colonocytes, while acetate and propionate reach systemic circulation and 
affect metabolism and function of peripheral organs (e.g. liver, pancreas, brain, muscle)4,20,21. Therefore fiber 
modulation of microbiota composition and functions has crystallized as a promising strategy to promote gut and 
host health.
Dietary fibers (DFs) as main substrate for the gut microbiota are key factors of the microbial network in the 
gut. In particular inulin and fructo-oligosaccharides (FOS) have repeatedly been shown to selectively modu-
late the gut microbiota in vitro and in vivo with benefits for host health (“prebiotic effect”)22–27. However, the 
lack of specific responses of bacterial groups has posed an important challenge in understanding the prebiotic 
mechanisms of most fibers12,28. Multiple studies aiming at identification of novel prebiotics, such as β-glucans, 
galacto-oligosaccharides (GOS) and xylo-oligosaccharides (XOS), have encountered the same challenge of func-
tional redundancy within phylogenetically diverse bacterial groups and limited understanding of the metabolite 
functions.
In vitro fermentation models are powerful approaches to investigate gut microbiota functionality without 
host effects in a highly controlled environment29. These models allow the strict control of physiologic parameters, 
such as retention time, pH, temperature and anaerobiosis, and medium composition used to mimic the diet. 
Colonic models from simple short-term batch fermentations to multistage long-term continuous flow models 
were developed30–32. Continuous models further control the medium flow rate, for culturing of microbiota in 
steady-state conditions, allowing a fiber to develop its full effect along the entire trophic chain, thereby increasing 
the physiological relevance of the experiment. In particular, continuous fermentation systems with immobilized 
gut microbiota were shown to simulate the high-cell density, biodiversity and long-term stability of the intestinal 
microbiota32. This prevents washout of less competitive bacteria and ensures the repeated exposure of a single 
microbiota to different fibers29,30,32. The PolyFermS model allows the parallel testing of different treatments on 
singular microbiota.
The aim of this study was therefore to investigate the effects of novel potential prebiotics on healthy adult gut 
microbiota using PolyFermS in vitro continuous colonic fermentation model mimicking the adult proximal colon 
microbiota. Immobilization of two distinct fecal microbiota obtained from two healthy adult donors was per-
formed. The two microbiota were propagated and stabilized in an inoculum reactor (IR) seeded with microbiota 
immobilized in polymer gel beads allowing continuous and prolonged culture of the microbiome31,33. The model 
design allowed parallel testing of four different dietary fiber supplementations (β-glucan, XOS, α-GOS and inu-
lin) compared to a control reactor with no supplemented fiber, all inoculated with the same microbiota produced 
in IR. The effect of dietary fibers derived from plants was tested at a physiological concentration mimicking a 
daily intake of 9 g fibers in test reactors for 5–7 days to reach pseudo-steady state conditions. Microbiota com-
position and diversity was monitored with 16S rRNA gene amplicon sequencing, and SCFAs analysis by HPLC.
Results
Donor selection and transfer to PolyFermS. Fecal microbiota of 30 healthy individuals were screened 
using 16S rRNA gene amplicon sequencing to select two fecal donors with distinct taxonomic profile for die-
tary fiber supplementation study. Fecal microbiota variation across the donors was stratified into enterotypes 
Ruminococcus, Bacteroides and Prevotella as decribed by Arumugam et al.34 (Fig. 1A). Two donors, D3 and D4, 
were selected based on the difference in their dominant microbial taxa. The microbiota composition of both 
donors was representative for a healthy human microbiota (Supplementary Table S2), with Firmicutes (D3: 51%; 
D4: 57%) and Bacteroidetes (D3: 26%; D4: 32%) as the dominant bacterial phyla. Donors differed from each other 
on family level with D3 fecal microbiota characterized by higher levels of Bacteroidaceae (D3: 17%; D4: 8%) and 
presence of Verrucomicrobiaceae (D3: 6%; D4: < 0%), and archaeal family Methanobacteriaceae (D3: 9%; D4: 
2%). Whereas D4 fecal microbiota was characterized by higher levels of Prevotellaceae (D4: 17%; D3: 0.1%) and 
Lachnospiraceae (D4: 13%; D3: 7%) compared to D3 fecal microbiota (Supplementary Table S2B). For assessing 
the α-diversity, the Shannon index for both fecal microbiota was calculated and both donors had a comparable 
Shannon index (D3: 5.8 ± 0.9; D4: 5.8 ± 0.9; Supplementary Table S3).
Fecal microbiota of both donors were studied in the PolyFermS continuous intestinal fermentation model 
operated with conditions mimicking the proximal colon microbiota. The model is composed of an inoculum 
reactor (IR), containing immobilized human adult fecal microbiota used to continuously inoculate several second 
stage control and experimental reactors mounted in parallel. The second stage reactors with the same complete 
microbiota allow comparing different treatments with a control. During 49 days of continuous operation of IRs 
inoculated with different donor microbiota, the microbial stability was assessed on phylogenetic and metabolic 
levels. The Shannon diversity, taking in account both abundance and evenness of species present in a sample, was 
reduced in the in vitro model compared with fecal microbiota (Supplementary Table S3). The mean Shannon 
index of IR and second stage untreated microbiota (CR) was 4.3 ± 0.1 for F1, containing D3 microbiota (Shannon 
index 5.8 ± 0.9), and 3.6 ± 0.2 for F2, containing D4 microbiota (Shannon index 5.8 ± 0.9). On family level the 
microbiota composition within each fermentation reflected well its specific donor microbiota (Supplementary 
Table S4 and Supplementary Table S5) as previously observed in similar PolyFermS setup32. Within F1 microbi-
ota of IR and untreated control reactor, Firmicutes (56%) and Bacteroidetes (26%) were the predominant phyla. 
In correspondence with the fecal D3 microbiota, F1 microbiota was characterized by high levels of bacterial 
families Bacteroidaceae (IR: 23 ± 5%; CR: 29 ± 6%) and Ruminococcaceae (IR: 18 ± 3%; CR: 11 ± 7%). Whereas 
F2 microbiota was dominated by Bacteroidetes (58%) over Firmicutes (36%) and characterized by high levels 
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of Prevotellaceae (IR: 53 ± 6%; CR: 53 ± 4%) and Ruminococcaceae (IR: 19 ± 4%; CR: 18 ± 2%), also in corre-
spondence with its donor fecal microbiota. Some bacterial families were detected at different abundances in vitro 
compared to the fecal sample. For example, in F1 increased abundances of Acidaminococcaceae (12 ± 1%; 0.3% 
in fecal sample) and Enterobacteriaceae (15 ± 4%; undetected in fecal sample) and in F2 Prevotellaceae (36 ± 6%; 
17.2% in fecal sample) and unclassified Lactobacillales (4 ± 1%; undetectable in fecal sample) were detected 
(Supplementary Table S2 and Supplementary Table S5). A clear spatial separation and clustering of F1 and F2 
microbiota was observed by Principle Coordinate Analysis (PCoA) on weighted UniFrac distance matrix on OTU 
level, indicating a distinct and stable microbial profile of the two donor microbiota in vitro (Fig. 1B).
Bacterial fermentation activity was monitored by SCFA analysis of fermentation effluents of PolyFermS reac-
tors along the complete fermentation period. After the initial colonization-stabilization period of 12 and 15 days, 
total SCFA concentrations in IR effluents were stable with 153 (±9) mM for 20 days in F1 and 123 (±10) mM for 
36 days in F2, respectively. Acetate was the predominant SCFA produced in both fermentations (F1: 55 ± 6 mM; 
F2: 69 ± 4 mM). Butyrate and propionate levels differed between both fermentations with F1 characterized by 
higher butyrate levels (F1: 38 ± 4 mM and F2: 29 ± 6 mM) and F2 characterized by higher propionate levels (F1: 
21 ± 3 mM and F2: 42 ± 5 mM) (Fig. 1C). The metabolic profiles of IR over the whole fermentation periods of 
36 and 42 days for F1 and F2, respectively, showed stable concentrations of the main SCFAs (Supplementary 
Figure S2).
Dietary fiber supplementation induces different metabolic and microbial responses in vitro 
depending on donor microbiota. The effects of dietary fibers β-glucan, XOS, α-GOS and inulin on 
metabolic and microbial responses of stable PolyFermS microbiota of F1 and F2 were tested at a concentration 
of 4 g/L in the fermentation medium, mimicking an estimated daily intake of 9 g/day, for 7 days alternated by 
re-stabilization phases of 5 days, and two repetitions (noted I and II) were done for dietary fiber application 
within F1 and F2, except for α-GOS. Supplementation was performed through addition of sterile, non-heated 
fiber to the complex medium. Metabolic response of both microbiota was assessed by measuring SCFA pro-
duction at the end of treatment (3 day sampling) and comparing to the production measured during the sta-
bilization period before a fiber treatment is applied. Addition of dietary fibers yielded an overall increase in 
total SCFA production for both microbiota in F1 and F2 compared to stabilization, with mean increase ranging 
from 3 to 54 mM (F1) and 16 to 38 mM (F2), indicating fermentation of all supplemented fibers (Supplementary 
Figure S3). Acetate production was significantly enhanced for both microbiota upon supplementation with XOS 
and α-GOS, whereas during β-glucan treatment acetate levels remained stable. Butyrate and propionate produc-
tions were also increased by fiber supplementation but with microbiota-dependent response. Butyrate production 
increased (between 2 and 96%) in F1 (D3), while propionate production was enhanced (between 3 and 40%) in 
F2 (D4) microbiota upon β-glucan, XOS, α-GOS and inulin supplementation (Fig. 2A and B and Supplementary 
Figure 1. (A) Variation in fecal microbiota among the 30 healthy individuals represented in an enterotype 
plot for 16S rRNA gene amplicon sequence dataset generated as described on http://enterotyping.embl.de/. (B) 
Principle Coordinate Analysis based on the weighted UniFrac distance matrix on OTU level generated from 
fecal and non-treated PolyFermS microbiota of fermentation 1 (F1 with donor 3 microbiota) and fermentation 2 
(F2 with donor 4 microbiota), showing conservation of the two distinct donor microbiota profiles in PolyFermS 
model. Microbiota included from inoculum reactor (IR) and control reactor (CR) from F1 on day 12, day 19, 
day 24 and day 31 and for F2 on day 8, day 14, day 19, day 25, day 31 and day 37. (C) Bar-plot representation of 
mean acetate (blue), propionate (red) and butyrate (green) concentrations (mM) of PolyFermS effluent samples 
of IR during stable operation phase and connection with experimental reactors (IR_F1: day 1–day 36; IR_F2: 
day 1–day 42).
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Table S6A). In addition, inulin also raised butyrate production in F2 (D4). Metabolic interactions within the 
PolyFermS microbiota upon fiber treatment were observed when inulin was supplemented. This is demonstrated 
by an increase in butyrate, when acetate levels remained stable or decreased (F1 treatment 2 and F2), but when 
acetate concentrations increased, butyrate levels remained stable (F1 treatment 1), suggesting cross-feeding of 
butyrate-producers on acetate.
Interestingly we did not observe a consistent change of a single OTU upon fiber supplementation, con-
firming the current hypothesis of high functional redundancy within the gut microbiota and suggesting a 
multi-strain response causing observed changes in SCFA production. Principle coordinate analysis (PCoA) 
on weighted UniFrac distances of the fiber-supplemented PolyFermS microbiota allowed us to identify taxa 
that stratify the microbiota of F1 and F2 in relation to the dietary fiber supplementation and their abun-
dances (Fig. 3A and B). Due to the different microbiota of F1 (Bacteroidaceae-Ruminococcaceae dominated) 
and F2 (Prevotellaceae-Ruminococcaceae dominated), the response on OTU level upon a dietary fiber was in 
some cases different. For example, α-GOS supplementation resulted in consistent higher levels compared to 
stabilization period of Lachnospiraceae in F2 microbiota during both treatment periods (I: 6 to 12% and II: 
5 to 10%; Supplementary Table S7B), also reflected by a Blautia (6) and Eubacterium rectale (25) OTU in the 
PCoA. Whereas in F1 microbiota Lachnospiraceae levels decreased upon α-GOS supplementation (18 to 13%, 
Supplementary Table S7A). In PCoA, β-glucan supplemented F1 microbiota was determined by Eubacteriaceae 
OTUs (E. siraeum (7) and E. rectale (6)), in accordance with higher Eubacteriaceae levels compared to stabiliza-
tion periods (I: 10 to 23% and II: 7 to 20%; Supplementary Table S7A). On the other hand, β-glucan supplemented 
Figure 2. Effect of dietary fiber supplementation on fermentation metabolite concentration (A and B) and 
microbiota of fermentation 1 (F1) (donor 3) and fermentation 2 (F2) (donor 4). Mean (black horizontal line) 
from 3 consecutive measurements of acetate, propionate and butyrate concentrations (mM) in the respective 
reactor at end of stabilization and treatment phase for F1 (D3 microbiota) (A) and F2 (D4 microbiota) (B). Two 
replicates are shown for each dietary fiber treatment.
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F2 microbiota was separated in the PCoA by a Sutterella wadsworthensis OTU (28). An increased relative abun-
dance of Prevotellaceae in both repetitions of β-glucan supplementation was also observed (I: 26 to 61% and II: 
54 to 58%; Supplementary Table S7B) compared to the previous stabilization period. Interestingly, inulin showed 
consistent changes in relative abundance upon supplementation, independent of the donor microbiota. After inu-
lin supplementation, the relative abundance of Ruminococcaceae increased in both fermentations (F1: 22 to 28% 
and F2: I: 13 to 19% and II: 16 to 22%; Supplementary Table S7B). No consistent changes in relative abundance 
of main bacterial families could be detected upon XOS supplementation in both microbiota (Supplementary 
Table 7). However, in the PCoA the XOS supplemented microbiota of F2 were both determined by an E. rectale 
OTU (10 and 25; Fig. 3B), which indicates a higher abundance of E. rectale in XOS supplemented F2 microbiota.
Reproducible metabolic response to dietary fiber supplementation in PolyFermS model with 
same microbiota. Advances in research are based on the reproducibility of previously published data or 
investigated results and findings35. In this study, we performed a third fermentation with D3 microbiota 15 
months after F1 with treatments inulin and α-GOS. In order to assess the microbial composition similarities 
or eventual differences after one year, the relative abundances (V4 region of 16S rRNA gene) of the different 
phyla and families were compared (Supplementary Table S8). At phylum level, fecal microbiota of donor D3 at 
both time points used to inoculate F1 and F3 was dominated by Firmicutes (F1 D3: 51% and F3 D3: 50%) and 
Bacteroidetes (F1 D3: 25% and F3 D3: 31%). The key bacterial families defining D3 microbiota remained stable 
with dominance of Bacteroidaceae (F1 D3: 17% and F3 D3: 22%) and Ruminococcaceae (F1 D3: 21% and F3 D3: 
16%) and presence of Verrucomicrobiaceae (F1 D3: 6% and F3 D3: 4%) and Methanobacteriaceae (F1 D3: 9% and 
F3 D3: 6%).
In order to assess reproducibility and stability of the D3 microbiota in our PolyFermS model, the fermentation 
effluent microbiota of the non-treated reactors were compared to fecal donor and F1 and F2 microbiota. PCoA of 
UniFrac distances (Fig. 4A and B) showed F1 and F3 microbiota (D3) were more similar to each other on OTU 
Figure 3. Effect of dietary fiber supplementation on microbiota (A and B) of fermentation 1 (F1; donor 3) 
and fermentation 2 (F2; donor 4). Principle components analysis (PCA) biplot showing variation among the 
PolyFermS microbiota of F1 (B) and F2 (D) after supplementation with dietary fibers XOS, a GOS, b glucan and 
inulin. Variables included in the PCA were relative abundance of OTUs (>0,05%) and OTUs are represented as 
numbers.
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composition (unweighted) and abundance (weighted) compared to F2 microbiota (D4), demonstrating the repro-
ducible conservation of donor microbiota profile in vitro. The abundance of the dominant bacterial families was 
also comparable between F3 and F1 microbiota in inoculum reactors with Bacteroidaceae (F3: 29%; F1: 26%) and 
Ruminococcaceae (F3: 19%; F1: 19%) as predominant families (Supplementary Table S8B).Total SCFA production 
was also comparable between F3 and F1 with 129 ± 7 mM and 123 ± 10 mM, respectively (Fig. 4C). There was a 
slight difference in SCFA profile in the IR effluents, with lower butyrate levels in F3 (22%) compared to F1 (31%) 
but comparable acetate (F3: 48%; F1: 45%) and propionate (F3: 20%; F1: 17%) concentrations (Fig. 4C).
After reaching stable SCFA profile in reactors during stabilization, supplementation with inulin or α-GOS 
resulted in significant increases of total SCFAs (Fig. 5A; Supplementary Table S6B). Similar to F1, addi-
tion of α-GOS (from 28 ± 2 to 44 ± 1 mM, during stabilization and treatment, respectively) or inulin (from 
30 ± 2 to 41 ± 3 mM) enhanced butyrate production, while inulin stimulated acetate production (from 61 ± 2 
to 66 ± 2 mM). α-GOS supplementation resulted in increased levels of Ruminococcaceae (from 24 to 31% 
during stabilization and treatment, respectively) and Bacteroidaceae (from 22 to 26%), (Supplementary 
Table S9). Simultaneously a decrease in Eubacteriaceae (17 to 10%) was observed. The relative abundance 
of Ruminococcaceae was increased by inulin supplementation (from 41 to 48%), while abundance of the 
Eubacteriaceae decreased (from 15 to 9%).
Discussion
In this study the effect of supplementation of four different dietary fibers on human gut microbiota was investi-
gated at the levels of metabolic and bacterial composition using a continuous in vitro fermentation system, mod-
eling adult proximal colon conditions. By using two distinct fecal microbiota composition we could demonstrate 
a consistent and donor-dependent butyrogenic or propionigenic response towards the fiber treatments.
Both on metabolic and phylogenetic levels we successfully maintained two distinct colon microbial commu-
nities in the PolyFermS reactors reflecting the corresponding fecal microbiota donor. Both fecal microbiota were 
dominated by Firmicutes and Bacteroidetes species and differed mainly on family level within the Bacteroidetes 
phylum with higher levels of Bacteroidaceae species in D3, low in D4, and high levels of Prevotellaceae in D4, low 
Figure 4. Reproducability over time of PolyFermS model inoculated with same healthy fecal donor (D3); F3 
was operated 15 months after F1. PCoA plots of weighted (A) and unweighted (B) were performed based on 
the UniFrac distance matrix generated from sequencing V4 region of 16S rRNA genes in samples from donor’s 
feces and fermentation effluents of F1 (D3), F2 (D4) and F3 (D3). Each circle represents a sample from feces 
and effluent samples from F1 (D3) (red), F2 (D4) (orange) and F3 (D3) (purple). Bar-plot representation of 
the mean acetate (blue), propionate (red) and butyrate (green) concentrations (mM) (C) of PolyFermS effluent 
samples of inoculum reactor (IR) during stable operation phase and connection with experimental reactors 
(IR_F1: day 1–day 36; IR_F3: day 1–day 23); D3, donor 3; F1, fermentation 1; F2, fermentation 2; D4, donor 4; 
F3, fermentation 3.
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in D3. Several other reports observed that individuals with high levels of Prevotella have low levels of Bacteroides 
and vice versa34,36,37, suggesting niche competition within the human gut microbiota. Abundance of Bacteroides 
has been associated with animal/fat-rich diets36,37, while high Prevotella abundance has been associated with 
plant-rich and vegetarian diets36,38. Difference in abundance of Bacteroidetes phylum between the two donor 
microbiota was preserved and even enhanced in our PolyFermS model for proximal colon microbiota, despite 
identical chime-simulating fermentation medium composition. The PolyFermS abundance levels fall within the 
range reported in a recently published large cohort of 1106 fecal microbiota of Western European individuals 
with Bacteroides: 0.1–72% and Prevotella: 0–56%39. Stable SCFA profiles were obtained in the untreated control 
reactors of F1 and F2, reflecting maintenance of functional stability of bacterial community during continuous 
operation of 36 and 43 days, respectively. The Prevotellaceae-dominated microbiota (F2) was characterized by 
high propionate production and can be explained by propionate –producing capacity of Prevotella species40. It was 
earlier reported that higher fecal propionate levels are associated with Prevotella species41,42. In another cohort it 
was shown that individuals with more than 20% Prevotella have higher levels of methylmalonyl-CoA mutase, a 
key enzyme involved in propionate production, in their fecal metaproteome43. The high butyrate production in F1 
(Bacteroidaceae-dominated) microbiota is likely due butyrate-producing Lachnospiraceae and Ruminococcaceae 
species, which were the second and third dominating families within F1. Bacteroidaceae species do not produce 
butyrate within the human gut40,44, but may contribute to the butyrate pool by their acetate production, used as 
co-substrate during butyryl-CoA-transferase route in gut bacteria45.
Our data showed that all dietary fibers supplemented in the PolyFermS microbiota increased SCFA produc-
tion, displaying fermentability of all tested substrates by both microbiota. Overall, F1 microbiota responded to 
all dietary fibers by increased butyrate production, whereas F2 microbiota showed increased propionate produc-
tion. This specific response was consistent among the different treatments and the three fermentations. Similar 
inter-individual differences in butyrogenic or propionigenic response were observed in static batch experiments 
with fecal microbiota supplemented with wheat bran particles or inulin46, and with FOS and two arabinoxy-
lan variants47. Comparable to our observations, Chen et al.47 showed that Prevotella-dominated microbiota 
responded by higher propionate production upon fiber supplementation in vitro. Both in F1 and F2, XOS and 
αGOS resulted in strong increase in acetate levels, which is produced by almost all heterotrophic gut bacteria48. 
Both dietary fibers were short-chain types, which makes them easier fermentable49 and it was shown in vitro 
that various intestinal bacteria can use GOS and XOS50. This broad-range utilization may explain the differ-
ent effects measured on microbiota composition upon XOS supplementation. Metabolic cross-feeding between 
acetate- and butyrate- producers resulting in higher butyrate levels was observed with inulin in both PolyFermS 
microbiota, and repetitions. Inulin can be degraded by different Bifidobacterium spp., Lactobacillus spp.51 and 
some butyrate-producing Roseburia spp.52, F. prausnitzii and Eubacterium rectale53. Bifidobacteria and lactoba-
cilli produce acetate and lactate, which can in turn be utilized by butyrate-producing bacteria. During these 
cross-feeding interactions on inulin-type fructans both commensalism (cross-feeding on acetate and lactate) 
and substrate competition occurs between both bacterial groups in co-culture experiments54. We observed a 
consistent increase in Ruminococcaceae, but no increase of Actinobacteriaceae (bifidobacteria), which suggests 
that in our set-up the inulin-degrading Ruminococcaceae (e. g. F. prausnitzii) produced butyrate while consuming 
the available acetate in the mixed microbial environment. Indeed, increased Ruminococcaceae levels upon inulin 
treatment was linked with an increase in a F. prausnitzii OTU, which is in accordance with in vitro55 and human 
observations56,57. Β-glucan supplementation resulted in increased butyrate and Eubacteriaceae levels in F1 micro-
biota, and increased propionate and Prevotellaceae levels in F2. Both changes in microbial composition explain 
the change in metabolic profile as Eubacteriaceae species produce butyrate and acetate, which becomes available 
Figure 5. Repetition of α-GOS and inulin supplementation to D3 microbiota in PolyFermS resulted in 
comparable higher butyrate productions and stimulates specific OTUs (PCA). (A) Mean (black horizontal 
line) from 3 consecutive measurements of acetate, propionate and butyrate concentrations (mM) in the 
respective reactor at end of stabilization and treatment phase for fermentation 1(F1) and fermentation 3 (F3) 
(donor 3).Two replicates are shown for each dietary fiber treatment. (B) Principle components analysis (PCA) 
biplot showing variation in the PolyFermS microbiota of F1 and F3 after supplementation with dietary fibers 
a GOS and inulin. Variables included in the PCA were relative abundance of OTUs (>0,05%) and OTUs are 
represented as numbers.
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for cross-feeding interactions, while Prevotellaceae produce propionate40. The increase in Bacteroides-Prevotella 
group and propionate production was also observed in vitro with oat β-glucan58. Prevotella can better ferment 
complex polysaccharides from the diet than Bacteroides59, which may explain their competitive advantage upon 
β-glucan supplementation.
Overall, we did not detect consistent or systematic changes in the microbiota composition upon dietary fiber 
supplementation. It appears that the microbiota modulation by dietary fibers occurs at species level as demon-
strated by Chung et al.55 in a continuous in vitro fermentation with three different fecal microbiota and dietary 
fibers as sole carbohydrate source. Due to the higher inter-individual variation at species level within the human 
gut microbiota, it can be expected that a single fiber will not induce a strong specific modification of the micro-
biota at species level in different individuals. Indeed, human intervention studies with dietary fibers showed 
marked inter-individual microbiota changes, which were depended on the individuals’ dominant microbiota 
composition9.
Compared with in vivo and human studies, there are limitations of the in vitro approach, since the models 
do not replicate all the conditions that occur in the colon, resulting in enriching and diminishing of bacterial 
populations. However, our data correspond well with dietary fiber fermentation in vivo and allowed insight into 
the complex cross-feeding mechanisms. In particular, we managed to show that dietary fibers induce dynamic 
responses depending on an individual’s specific microbiota. Main strength of in vitro fermentation models for 
prebiotic research is that one can follow the in situ SCFA production upon treatment, whereas in human interven-
tion studies fecal SCFA concentrations are only a proxy for colonic fermentation and mainly a result of absorption 
of the SCFA in the intestine and lack thereof. Our approach of repeated dietary fiber supplementation to a stable 
and active gut microbiota in a continuous fermentation model allowed elucidating direct and indirect metabolic 
and compositional shifts that can occur in the human gut using long-term supplementation. This is in contrast to 
often used static batch incubations with fecal microbiota and dietary fibers, which reflect a direct effect of a fiber 
on the growth and activity of fast substrate utilizers and often neglects the indirect effects or long term shifts that 
might have the most profound effect on microbiome composition.
To summarize, our study showed that two distinct fecal microbial consortia maintained in vitro in the 
PolyFermS continuous intestinal fermentation model inoculated with immobilized adult fecal microbiota 
responded differently to dietary fiber supplementation on metabolic and compositional level. Irrespective to the 
dietary fiber supplemented. The Bacteroidaceae-Ruminococcaceae dominated microbiota produced more butyrate 
while the Prevotellaceae-Ruminococcaceae dominated microbiota produced more propionate. No fiber-specific 
change on phylogenetic level was observed, but changes in abundance of specific families or species level OTUs 
within a microbiota together with cross-feeding interactions between the different functional groups could 
explain the observed changes in SCFA profiles. Our data suggest that the metabolic profile of SCFA may be the 
most suitable and robust read-out to characterize the microbiota-modulating effect of a fiber and emphasize on 
the importance to understand inter-individual responses to a prebiotic treatment for mechanistic understanding 
and human application.
Material and Methods
Fecal bacteria immobilization. Fecal samples were donated by two healthy individuals (male, age 33 and 
32), who did not receive antibiotic or probiotic supplementation for at least 3 months before donation. Fecal 
samples were collected in a sterile 50 mL Falcon tube in an airtight container together with one Anaerogen sachet 
(Oxoid) to obtain anaerobic conditions until transfer into an anaerobic chamber (10% CO2, 5% H2 and 85% 
N2) within 3 h (Coy Laboratories, Ann Arbor, MI, USA). Fecal bacteria were immobilized in 1–2 mm gel beads 
consisting of gellan gum (2.5%, w/v), xanthan (0.25%, w/v) and sodium citrate (0.2%, w/v) under anaerobic 
conditions as previously described in detail30,32. Sixty mL of freshly produced fecal beads were transferred in 
the IR bioreactor containing 140 mL of nutritive medium. For bead colonization, three consecutive fed-batch 
fermentations were carried out by replacing 100 mL fresh nutritive medium every 8–12 h. Bacteria, growing close 
to the bead surface are continuously released into the growth medium due to active cell growth in the high-bio-
mass-density peripheral layer29,60.
Nutritive medium. The nutritive medium was based on the composition described by Macfarlane et al.61 
for simulation of the chyme in the adult human colon. It included (g L−1 of distilled water): pectin (citrus) (2), 
xylan (oat spelts) (2), arabinogalactan (larch) (2), guar gum (1), inulin (1), soluble potato starch (5), mucine (4), 
casein acid hydrolysate (3), peptone water (5), tryptone (5), yeast extract (4.5), L-cysteine HCl (0.8), bile salts 
(0.4), KH2PO4 (0.5), NaHCO3 (1.5), NaCl (4.5), KCl (4.5), MgSO4 anhydrated (0.61), CaCl2*2 H2O (0.1), MnCl2* 
4 H2O (0.2), FeSO4* 7H20 (0.005), hemin (0.05) and Tween 80 (1 mL). Prior sterilization (20 min, 120 °C), the pH 
of the medium was adjusted to 5.7. One mL of a filter-sterilized (0.2 μm pore-size) vitamin solution62 was added 
to the sterilized and cooled down medium. All components of the fermentation medium were purchased from 
Sigma-Aldrich Chemie (Buchs, Switzerland), except for peptone water (Oxoid AG, Pratteln, Switzerland), inulin 
(Orafti®, RPN Food-technology AG, Sursee, Switzerland), bile salts (Oxoid AG), tryptone (Becton Dickinson 
AG, Allschwill, Switzerland), yeast extract (Merck, Darmstadt, Germany), KH2PO4 (VWR International AG), 
NaHCO3 (Fluka, Buchs, Switzerland), NaCl (VWR international AG, Dietikon, Switzerland), KCl (Fluka, Buchs, 
Switzerland) and KH2PO4 (VWR International AG).
Four different dietary fibers (inulin-type fructan, β-glucan, XOS, α-GOS) were investigated (Supplementary 
Table S1) and supplemented to sterile nutritive medium at a concentration of 4 g L−1, calculated for an estimated 
daily intake of 9 g L−1, accounting for the reactor volume of 0.2 L compared to 0.75 L for the proximal colon vol-
ume, and a chime medium supply of 0.6 L medium per day, giving a mean retention time of 8 h. Complete hydra-
tion of dietary fibers was allowed for 24 h under high speed stirring at 4 °C, as presented below.
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Simulation of proximal colon microbiota and treatment with dietary fibers. Experimental 
set-up. The set-up of the PolyFermS model was adapted for the aim of the study and is schematized in Fig. 6A. 
The continuous fermentations were carried out for up to 42 days in a two-stage design with a total of six bioreac-
tors (Sixfors, Infors, Bottmingen, Switzerland). Each reactor was operated with conditions selected to mimic the 
adult proximal colon (pH 5.7, stirring at 120 rpm, 37 °C, and mean retention time of 8 h). Anaerobiosis was main-
tained through continuous headspace flushing with CO2, and a constant pH of 5.7 was maintained by addition of 
2.5 M NaOH. IR had an operation volume of 200 mL and was inoculated with 60 mL of fecal beads and connected 
via a peristaltic pump (Reglo, Ismatec, Glattbrugg, Switzerland) to all second stage reactors, one control reactor 
(CR) and four treatment reactors (TR1-4) operated in parallel. All reactors were operated at a working volume 
of 200 mL. Fresh sterile nutritive medium was continuously supplied to IR at a flow rate of 25 mL/h, and second 
stage reactors were inoculated with 5% (v/v) (1.25 mL/h) IR effluent and supplied with 95% (v/v) (23.75 mL/h) 
fresh fermentation medium.
Experimental procedure. An initial colonization and stabilization phase of up to 15 days, prior experimentation 
was done (Fig. 6B). Each treatment was performed for 7 days for reaching a stable state, monitored by metabolite 
analysis and base consumption. The treatment periods were alternated with re-stabilization phases of 5–7 days, 
aiming to washout effects of the previous applied treatment and re-establishment of a microbiota composition 
similar to that in IR. The DFs (Supplementary Table S1) were added to the medium (4 g/L) and connected to 
assigned treatment reactor.
Effluent samples were taken daily and separated into bacterial pellet (10 min of centrifugation at 14.000 g at 
4 °C) and supernatant, and stored at −20 °C until further analysis. Stability of the reactor microbial communities 
was monitored by daily measurements of main fermentation metabolites concentrations in sample supernatant. 
Standard observed variations in the PolyFermS fermentation metabolites are normally lower than 10% and used 
to define functional microbial stability, before starting and analyzing samples of a treatment period.
Figure 6. Experimental set-up (A) and time schedule (B) of the continuous fermentation model with inoculum 
reactor (IR) and control (CR) and treatment (TR) reactors. CR and TR’s were fed with effluent from IR and 
with nutritive medium during stabilization and washout periods. TRs were fed with effluent from IR and 
supplemented fermentation medium (4 g/L dietary fiber) during treatment periods.
www.nature.com/scientificreports/
1 0SCiEnTiFiC RePoRTs |  (2018) 8:4318  | DOI:10.1038/s41598-018-22438-y
Microbial metabolite analysis. High performance liquid chromatography (HPLC) analysis (Thermo 
Fisher Scientific Inc. Accela, Wohlen, Switzerland) was performed to determine the concentrations of SCFAs 
(acetate, butyrate and propionate), branched-chain fatty acids (BCFAs) (isobutyrate, valerate and isovalerate) 
and intermediate metabolites (lactate and formate) produced by the microbiota in the reactor effluents. Analyses 
were performed with a Hitachi LaChrome device (Merck, Dietikon, Switzerland) using a Cation-H refill car-
tridge (30 × 4.6 mm) connected to an Aminex® HPX-87H (300 × 7.8 mm) column. Due to biofilm formation, 
supernatants of IR and TR reactors were diluted in ultrapure water and filtered through a 0.22 or 0.45 μm nylon 
membrane (Infochroma AG, Zug, Switzerland) into glass vials and sealed with crimp-caps. Around 40 μL of the 
sample were injected into the HPLC with a flow rate of 0.4 mL min−1 and H2SO4 as an eluent.
Microbial community analysis. Genomic DNA extraction. The genomic DNA was extracted from 200 mg 
feces and pellet of 2 mL PolyFermS effluent using the FastDNA® SPIN Kit for Soil (MP Biomedicals, Illkirch, 
France). Total DNA concentration (ng/μL) and purity was determined by spectrophotometry using Nanodrop 
(Nanodrop ND 1000 Spectrophotometer, Thermo Scientific, Wilmington, USA).
Microbiota profiling with 16S rRNA gene amplicon sequencing. The bacterial composition of the fecal 
and PolyFermS samples was determined using tag-encoded 16S rRNA gene Miseq-based (Illumina, 
CA, USA) high throughput sequencing. DNA samples of the last day of each experimental period of 
each PolyFermS reactor were selected for assessing the bacterial composition and its stability in the 
PolyFermS model and the shifts after prebiotic treatments. The V4 region of the 16S rRNA gene was ampli-
fied with modified primers 515 F (TATGGTAATTGTGTGNCAGCMGCCGCGGTAA) and 806 R 
(AGTCAGTCAGCCGGACTACHVGGGTWTCTAAT). Library preparation and sequencing was performed by 
StarSEQ (Mainz, Germany) using for sequencing one MiSeq cell and the V2 2 × 250 bp paired end Next Tera 
chemistry supplemented with 20% of PhiX.
The raw data set containing pair-ended reads with corresponding quality scores were merged using settings 
as previously mentioned63. The minimum length of merged reads was 200 bp. Quantitative Insight Into Microbial 
Ecology (QIIME) open source software package (1.7.0, 1.8.0 and 1.9.0) was used for subsequent analysis steps64. 
Purging the dataset from chimeric reads and constructing de novo Operational Taxonomic Units (OUT) was 
conducted using the UPARSE pipeline65. The custom human intestinal 16S rRNA database (HITdb) was used as 
a reference database66. Alpha and beta diversity analysis was performed as previously described using iterative 
subsampling (36,000 reads/sample)67.
Statistical analysis. All statistical analysis for HPLC were carried out using the SigmaPlot 13.0 version, San 
Jose, California, USA. HPLC Data are expressed as means ± Standard deviations (SD) of three days at the end 
of the stabilization and treatment period of each fermentation. HPLC data were compared between stabilization 
and treatment phase using the nonparametric Shapiro-Wilk test. P-values < 0.05 were considered significant. 
Brown-Forsythe test was used to determine differences between stabilization and treatment periods.
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